Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

BACKGROUND: Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM in vitro and...

Descripción completa

Detalles Bibliográficos
Autores principales: Erguven, Mine, Bilir, Ayhan, Yazihan, Nuray, Ermis, Ezgi, Sabanci, Akin, Aktas, Esin, Aras, Yavuz, Alpman, Vehbi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135492/
https://www.ncbi.nlm.nih.gov/pubmed/21651812
http://dx.doi.org/10.1186/1475-2867-11-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135492/
https://www.ncbi.nlm.nih.gov/pubmed/21651812
http://dx.doi.org/10.1186/1475-2867-11-18

Ejemplares similares